ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Pain Management Research
Is there hope for degenerative disk disease?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 274362" data-attributes="member: 3"><p>Thanks [USER=43589]@BigTex[/USER] </p><p></p><p>I got my L2-L5 laminectomy 10 days ago and waiting for inflammation to go down to determine if my symptoms will get better.</p><p></p><p>Good luck!</p><p></p><p>I would not qualify due to several exclusions:</p><p></p><p>Exclusion Criteria:</p><p></p><p>To qualify for enrollment in this study, patients must meet none of the exclusion criteria as follows.</p><p></p><p>Prior epidural, sacroiliac joint, or facet injections at any lumbosacral level within the past 4 weeks (e.g., transforaminal, interlaminar, caudal)</p><p>Prior interventional procedures of other types at any lumbosacral level at any time (e.g., intradiscal injection, basivertebral nerve ablation, biacuplasty; radiofrequency (RF) ablation, spinal cord stimulator, others)</p><p>Prior spine surgery at any lumbosacral level at any time (e.g., discectomy, decompression, instrumentation, fusion, fracture treatment, others)</p><p>Prior fracture at any lumbar level</p><p>Significant neurologic symptoms:</p><p></p><p>Grade 3/5 or lower strength in any lumbar myotome</p><p>Sensory deficit in a clearly radicular or sensory dermatome</p><p>MRI evidence of disc height loss > 2/3 of adjacent disc at any level to be injected, determined by the independent radiologic central lab</p><p>MRI evidence of other disc degeneration: Pfirrmann Grade 3-5 at any level not to be injected, determined by the independent radiologic central lab</p><p>MRI evidence of disc herniation with neural compression at any level, determined by the independent radiologic central lab</p><p>MRI evidence of significant stenosis of the central canal at any level, determined by the independent radiologic central lab</p><p>MRI evidence of foraminal stenosis with neural compression at any level, determined by the independent radiologic central lab</p><p>MRI evidence of moderate-to-severe facet arthrosis with edema at any level, determined by the independent radiologic central lab</p><p>Spondylolisthesis (antero or retrolisthesis) > 25% at any level, determined by the independent radiologic central lab</p><p>Lumbar coronal deformity, determined by the independent radiologic central lab:</p><p></p><p>a. L1-S1 regional deformity > 25 degrees</p><p></p><p>Spondylolysis at any level</p><p>Lumbar inflammatory spondylitis</p><p>Recent history (previous six months) of chemical or alcohol dependence</p><p>Chronic narcotic use for more than defined as a daily dose of greater than 40 Morphine Equivalent Units (MEUs)</p><p>Depression or Somatization defined through the Distress and Risk Assessment Method (DRAM) scoring with Zung score > 33 or Zung > 17 and the Modified Somatic Perception Questionnaire (MSPQ) score > 12</p><p>Extreme obesity, defined by NIH Clinical Guidelines Body Mass Index (BMI > 40)</p><p>A QT duration corrected for heart rate by Fridericia's formula (QTcF) > 470 millisecond (msec)</p><p>Active systemic infection</p><p>Infection at the site of procedure pre-operatively</p><p>Cauda equina syndrome or neurogenic bowel/bladder dysfunction</p><p>Any terminal, systemic, or autoimmune disease including fibromyalgia, which may, in the opinion of the Principal Investigator compromise a subject's ability to comply with study procedures, and/or confound data</p><p>Metabolic bone disease (e.g., osteoporosis/osteopenia, gout, osteomalacia, Paget's disease)</p><p>Any disease, condition or surgery which might impair healing, such as:</p><p></p><p>Active malignancy</p><p>History of metastatic malignancy</p><p>Currently experiencing an episode of major mental illness (psychosis, major affective disorder, or schizophrenia), or manifesting physical symptoms without a diagnosable medical condition to account for the symptoms, which may indicate symptoms of psychological rather than physical origin</p><p>Any planned surgical procedure within the subject participation period (screening through the 12 Month Visit)</p><p>Any clinically relevant laboratory result on the screening visit Chem-12, hematology, or coagulation panels</p><p>Pregnancy at the time of screening, randomization, or planning to become pregnant during the first 3 months of follow-up</p><p>Currently a prisoner</p><p>Participation in any other investigational drug, biologic, or medical device study within the last 6 months prior to study procedure</p><p>Receiving Work Compensation benefits or engaged in personal spinal injury medical/legal litigation</p><p>Patient cannot be currently using the prohibited medications listed in the protocol</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 274362, member: 3"] Thanks [USER=43589]@BigTex[/USER] I got my L2-L5 laminectomy 10 days ago and waiting for inflammation to go down to determine if my symptoms will get better. Good luck! I would not qualify due to several exclusions: Exclusion Criteria: To qualify for enrollment in this study, patients must meet none of the exclusion criteria as follows. Prior epidural, sacroiliac joint, or facet injections at any lumbosacral level within the past 4 weeks (e.g., transforaminal, interlaminar, caudal) Prior interventional procedures of other types at any lumbosacral level at any time (e.g., intradiscal injection, basivertebral nerve ablation, biacuplasty; radiofrequency (RF) ablation, spinal cord stimulator, others) Prior spine surgery at any lumbosacral level at any time (e.g., discectomy, decompression, instrumentation, fusion, fracture treatment, others) Prior fracture at any lumbar level Significant neurologic symptoms: Grade 3/5 or lower strength in any lumbar myotome Sensory deficit in a clearly radicular or sensory dermatome MRI evidence of disc height loss > 2/3 of adjacent disc at any level to be injected, determined by the independent radiologic central lab MRI evidence of other disc degeneration: Pfirrmann Grade 3-5 at any level not to be injected, determined by the independent radiologic central lab MRI evidence of disc herniation with neural compression at any level, determined by the independent radiologic central lab MRI evidence of significant stenosis of the central canal at any level, determined by the independent radiologic central lab MRI evidence of foraminal stenosis with neural compression at any level, determined by the independent radiologic central lab MRI evidence of moderate-to-severe facet arthrosis with edema at any level, determined by the independent radiologic central lab Spondylolisthesis (antero or retrolisthesis) > 25% at any level, determined by the independent radiologic central lab Lumbar coronal deformity, determined by the independent radiologic central lab: a. L1-S1 regional deformity > 25 degrees Spondylolysis at any level Lumbar inflammatory spondylitis Recent history (previous six months) of chemical or alcohol dependence Chronic narcotic use for more than defined as a daily dose of greater than 40 Morphine Equivalent Units (MEUs) Depression or Somatization defined through the Distress and Risk Assessment Method (DRAM) scoring with Zung score > 33 or Zung > 17 and the Modified Somatic Perception Questionnaire (MSPQ) score > 12 Extreme obesity, defined by NIH Clinical Guidelines Body Mass Index (BMI > 40) A QT duration corrected for heart rate by Fridericia's formula (QTcF) > 470 millisecond (msec) Active systemic infection Infection at the site of procedure pre-operatively Cauda equina syndrome or neurogenic bowel/bladder dysfunction Any terminal, systemic, or autoimmune disease including fibromyalgia, which may, in the opinion of the Principal Investigator compromise a subject's ability to comply with study procedures, and/or confound data Metabolic bone disease (e.g., osteoporosis/osteopenia, gout, osteomalacia, Paget's disease) Any disease, condition or surgery which might impair healing, such as: Active malignancy History of metastatic malignancy Currently experiencing an episode of major mental illness (psychosis, major affective disorder, or schizophrenia), or manifesting physical symptoms without a diagnosable medical condition to account for the symptoms, which may indicate symptoms of psychological rather than physical origin Any planned surgical procedure within the subject participation period (screening through the 12 Month Visit) Any clinically relevant laboratory result on the screening visit Chem-12, hematology, or coagulation panels Pregnancy at the time of screening, randomization, or planning to become pregnant during the first 3 months of follow-up Currently a prisoner Participation in any other investigational drug, biologic, or medical device study within the last 6 months prior to study procedure Receiving Work Compensation benefits or engaged in personal spinal injury medical/legal litigation Patient cannot be currently using the prohibited medications listed in the protocol [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Pain Management Research
Is there hope for degenerative disk disease?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top